Sensitive Detection of Minimal Residual Disease in Patients Treated for Early-Stage Breast Cancer

Reading a very cool paper and here comes #FGbio (https://t.co/XrzRmcqgs7) @nilshomer this won't stop being cool to see!! https://t.co/udGvwTyv6d

Detection of Minimal Residual Disease could be a great tool for surgeons treating colorectal cancer. @mleonare @marianog65 @h_guadalajara @CirujanosMad @AECP_FAECP @delaportillaMD @CuestaLab @operemos

Tracking large numbers of individualized tumor mutations in cfDNA can improve MRD detection, but its sensitivity is driven by the number of tumor mutations available to track. https://t.co/rAPiMWDyT1

Sensitive Detection of Minimal Residual Disease in Patients Treated for Early-Stage Breast Cancer https://t.co/TbIVu5rEQj